Axiom Therapeutics
EF 2024 · Plug and Play · ML-driven covalent inhibitors for oncology teams.
Same space
| Company | Category | Status | Program |
|---|---|---|---|
 TheremiaShared: pharmaceuticals, biotechnology, drivenNot statedAI | AI | Not stated | EF2024 |
 immunitoAIShared: pharmaceuticals, biotechnology, drivenNot statedAI | AI | Not stated | EF2021 |
 ExogeneShared: biotechnology, oncologyNot statedAI | AI | Not stated | EF2020 |
 PolymerizeShared: biotechnology, drivenNot statedAI | AI | Not stated | EF2020 |
 Tetsuwan ScientificShared: biotechnology, drivenNot statedAI | AI | Not stated | EF2024 |
Also from EF
All of EF
Programs
| Program | Cohort | Source |
|---|---|---|
 Entrepreneur First | 2024 | EF Page |
 Plug and Play | Not stated | Plug and Play Page |
About Axiom Therapeutics
- Category
- Other
- Location
- London
- Checked
- 2h ago
Tags: Biotechnology, Pharmaceuticals
Axiom Therapeutics: questions
Which accelerators did Axiom Therapeutics go through?
Axiom Therapeutics is listed by Entrepreneur First (2024), Plug and Play.
Where is Axiom Therapeutics based?
Axiom Therapeutics lists London as its location on Entrepreneur First's page.
Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.